Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

Genen­tech is tak­ing its spinal mus­cu­lar at­ro­phy aware­ness ef­forts to New York with an orig­i­nal mu­si­cal com­e­dy. The show, called “Most Like­ly Not To…” will

Mer­ck said Keytru­da sales jumped 21% to $6.6 bil­lion in the fourth quar­ter of the year, dri­ven by new ap­provals in ear­li­er-stage in­di­ca­tions for breast